Company profile
Drugparadigm
From PROTACs to Peptides, Your AI Partner for Next-Gen Therapeutic Modalities
- Industry
- Think Tanks
- Employees
- 32
- Headquarters
- Hyderabad, Telangana
- Founded
- 2024
- LinkedIn followers
- 419
- Office locations
- 1
Drugparadigm company summary
Drugparadigm is a company in the Think Tanks industry, headquartered in Hyderabad, Telangana, founded in 2024. On LinkedIn the company has around 32 employees and 419 followers. Its listed specialties include AI Driven Drug Discovery, Computational Chemistry, Artificial Intelligence, Biology.
What technology does Drugparadigm use?
No technologies detected yet. Warmrank rechecks company websites on a rolling basis.
About Drugparadigm
Drugparadigm is an AI research startup focused on accelerating the discovery and development of next-generation therapeutic modalities. We build and apply advanced deep learning models that help researchers design, evaluate, and prioritize novel drug candidates across multiple modern therapeutic modalities. Our work spans three core discovery and therapeutic focus areas: 1. Targeted Protein Degradation: We develop deep learning models for degradation-based modalities such as PROTACs and molecular glues, supporting rational design, complex formation, permeability optimization, and prediction of degradation potential. 2. Targeted Drug Delivery (Oncology Therapeutics): We build predictive deep learning models for delivery-based modalities such as ADCs and PDCs to improve targeting precision, manage toxicity, optimize drug-to-antibody ratio (DAR), and prioritize effective therapeutic constructs. 3. Affinity-Centric Molecular Design: We design and evaluate both small and large molecules using AI-driven, pocket-aware and structure-guided approaches, along with advanced generative models for macrocyclization, to improve binding affinity, specificity, and functional inhibition across complex therapeutic targets. We offer a suite of research-grade deep learning models that operate directly on standard molecular representations, including SMILES strings, SDF/PDB structure files, and FASTA protein sequences. These models can be used as standalone components for specific prediction or generation tasks, or integrated directly into existing drug discovery pipelines and workflows without requiring specialized hardware or complex infrastructure. Whether you are an independent researcher, a biotech startup, an academic or industrial research lab, or a large pharmaceutical organization, Drugparadigm supports faster experimentation, informed decision-making, and systematic exploration across complex therapeutic modalities.
Specialties
Where is Drugparadigm located?
Drugparadigm lists 1 location.
Compare companies similar to Drugparadigm
More companies in Think Tanks.
| Company | Industry | Employees | Founded | Headquarters |
|---|---|---|---|---|
Drugparadigm drugparadigm.com | Think Tanks | 32 | 2024 | Hyderabad, Telangana |
 Chief chief.com | Think Tanks | 7,695 | 2019 | New York, NY |
 Council on Foreign Relations cfr.org | Think Tanks | 2,273 | 1921 | New York, NY, US |
| Think Tanks | 1,761 | 1962 | Washington, DC | |
 The Brookings Institution brookings.edu | Think Tanks | 919 | 1916 | Washington, DC |
| Think Tanks | 363 | 1958 | London, London | |
| Think Tanks | 506 | - | Winnipeg, Manitoba | |
 Pew Research Center pewresearch.org | Think Tanks | 262 | 2004 | Washington, District of Columbia |
 Circle Economy circle-economy.com | Think Tanks | 81 | 2011 | Amsterdam, Noord-Holland |
| Think Tanks | 418 | 2010 | New Delhi, Delhi | |
 Pavilion joinpavilion.com | Think Tanks | 5,402 | 2016 | New York, NY |
Frequently asked questions about Drugparadigm
What does Drugparadigm do?
Drugparadigm is an AI research startup focused on accelerating the discovery and development of next-generation therapeutic modalities. We build and apply advanced deep learning models that help researchers design, evaluate, and prioritize novel drug candidates across multiple modern therapeutic modalities. Our work spans three core discovery and therapeutic focus areas: 1. Targeted Protein Degradation: We develop deep learning models for degradation-based modalities such as PROTACs and molecular glues, supporting rational design, complex formation, permeability optimization, and prediction of degradation potential. 2. Targeted Drug Delivery (Oncology Therapeutics): We build predictive deep learning models for delivery-based modalities such as ADCs and PDCs to improve targeting precision, manage toxicity, optimize drug-to-antibody ratio (DAR), and prioritize effective therapeutic constructs. 3. Affinity-Centric Molecular Design: We design and evaluate both small and large molecules using AI-driven, pocket-aware and structure-guided approaches, along with advanced generative models for macrocyclization, to improve binding affinity, specificity, and functional inhibition across complex therapeutic targets. We offer a suite of research-grade deep learning models that operate directly on standard molecular representations, including SMILES strings, SDF/PDB structure files, and FASTA protein sequences. These models can be used as standalone components for specific prediction or generation tasks, or integrated directly into existing drug discovery pipelines and workflows without requiring specialized hardware or complex infrastructure. Whether you are an independent researcher, a biotech startup, an academic or industrial research lab, or a large pharmaceutical organization, Drugparadigm supports faster experimentation, informed decision-making, and systematic exploration across complex therapeutic modalities.
How many employees does Drugparadigm have?
Drugparadigm has around 32 employees on LinkedIn.
Where is Drugparadigm headquartered?
Drugparadigm is headquartered in Hyderabad, Telangana.
When was Drugparadigm founded?
Drugparadigm was founded in 2024.
Build a lead list from companies like Drugparadigm
Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.